71610 0188 98
Gabapentin Capsule
Product Images NDC 71610-188
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Formula (Gabapentin Fig1)
This text seems to be part of a mathematical formula used to calculate something related to creatinine levels and weight of patients aged 140 years and above. Unfortunately, without additional context or information, it is difficult to determine the specific calculation being made or the purpose behind it.*
Figure 1 (Gabapentin Fig2)
Figure 2 (Gabapentin Fig3)
This appears to be a chart displaying mean pain scores for a study with a 3-week dose titration period, followed by a 4-week fixed dose period. The chart appears to compare the effectiveness of a placebo versus two different doses of Gabapentin (1800mg/day and 2400mg/day) on pain reduction. The "Baseline" section of the chart may represent initial pain scores before any treatment was given.*
Figure 3 (Gabapentin Fig4)
The text is a table presenting the proportion of responders (patients with ≥ 50% reduction in pain score) in controlled PHN studies. The table includes data for two studies with the percentage of responders for each treatment group (placebo, GBP 3600, GBP 1800, GBP 2400), at the endpoint. Additionally, the table has two statistical values, #p<001 and 5D < 0.001, but there is not enough context to interpret their meanings.*
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)
Chemical Structure (Gabapentin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
